CRDF

Cardiff Oncology Inc

0.8745

Jul 16 • 03:59PM ET -0.0148 (-1.66%)

0.9022

Aftermarket • 07:54PM ET +0.0277 (3.17%)

Healthcare Biotechnology USA Micro NASD

Jul 15, 8:06 AMCardiff Oncology announces $10 million registered direct offering of common stock and warrants with officer and director participation

Peers: AARD AGEN BMEA CNTB GALT IMUX KZIA NTHI SPRO VRCA

| Held by: VTI VXF IWC DFAC AVSC

Index	-
Market Cap	59.79M
Enterprise Value	14.38M
Income	-44.79M
Sales	0.53M
Book/sh	0.51
Cash/sh	0.67
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	31
IPO	Jul 27, 2004

P/E	-
Forward P/E	-
PEG	-
P/S	112.81
P/B	1.72
P/C	1.30
P/FCF	-
EV/EBITDA	-
EV/Sales	27.13
Quick Ratio	3.27
Current Ratio	3.27
Debt/Eq	0.02
LT Debt/Eq	0.00
Option/Short	Yes / Yes

EPS (ttm)	-0.67
EPS next Y	-0.82
EPS next Q	-0.12
EPS this Y	1.32%
EPS next Y	-20.42%
EPS next 5Y	-17.89%
EPS past 3/5Y	8.24% 8.71%
Sales past 3/5Y	15.39% 10.13%
EPS Y/Y TTM	28.59%
Sales Y/Y TTM	-10.71%
EPS Q/Q	10.54%
Sales Q/Q	-62.39%
Earnings	May 14 AMC
EPS/Sales Surpr.	-33.53% -53.72%

Insider Own	8.54%
Insider Trans	15.34%
Inst Own	30.02%
Inst Trans	-4.66%
ROA	-66.82%
ROE	-84.79%
ROIC	-128.96%
Gross Margin	-70.86%
Oper. Margin	-9033.90%
Profit Margin	-8530.86%
SMA20	-29.37%
SMA50	-40.72%
SMA200	-55.15%
Trades

Shs Outstand	68.37M
Shs Float	62.53M
Short Float	20.49%
Short Ratio	9.09
Short Interest	12.81M
52W High	4.55 -80.80%
52W Low	0.83 5.36%
Volatility	9.76% 9.08%
ATR (14)	0.14
RSI (14)	27.64
Beta	1.46
Rel Volume	2.14
Avg Volume	1.41M
Volume	3,015,960

Perf Week	-33.75%
Perf Month	-38.42%
Perf Quarter	-48.56%
Perf Half Y	-69.53%
Perf YTD	-68.88%
Perf Year	-80.21%
Perf 3Y	-37.98%
Perf 5Y	-84.97%
Perf 10Y	-99.76%
Recom	2.00
Target Price	6.21
Prev Close	0.89
Price	0.87
Change	-1.66%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-03-26	Downgrade	Craig Hallum	Buy → Hold	$2
Jun-01-26	Downgrade	TD Cowen	Buy → Hold
Jun-01-26	Downgrade	H.C. Wainwright	Buy → Neutral
Jan-05-26	Initiated	Noble Capital Markets	Outperform	$12
Jul-08-25	Initiated	Ladenburg Thalmann	Buy	$19
Jun-24-25	Initiated	Jefferies	Hold	$3.50
Sep-06-24	Initiated	Craig Hallum	Buy	$8
Jan-05-22	Initiated	William Blair	Outperform
Dec-08-21	Initiated	Robert W. Baird	Outperform	$19
Aug-09-21	Resumed	Maxim Group	Buy	$30 → $20
Oct-22-20	Initiated	H.C. Wainwright	Buy	$27
Oct-08-20	Initiated	Piper Sandler	Overweight	$25

Show Previous Ratings

Jul-15-26 10:54AM	Cardiff Oncology Announces $10 Million Registered Direct Offering to Strengthen Working Capital (InvestorsHub) -32.11%
08:00AM	Cardiff Oncology Announces $10 Million Registered Direct Offering (GlobeNewswire)
Jun-02-26 09:06AM	Cardiff Oncology Announces Presentation of Positive Results from its Randomized, Controlled Phase 2 Trial of Onvansertib in First-Line RAS-Mutated mCRC at the 2026 ASCO Annual Meeting (GlobeNewswire)
Jun-01-26 04:01PM	Cardiff Oncology to Participate in the Jefferies Global Healthcare Conference (GlobeNewswire) -22.11%
May-21-26 05:00PM	Cardiff Oncology Announces Webcast to Discuss Updated Phase 2 CRDF-004 Data for Onvansertib in First-Line RAS-Mutated mCRC (GlobeNewswire)
04:22PM	Loading…
May-14-26 04:22PM	Cardiff Oncology: Q1 Earnings Snapshot (Associated Press)
04:10PM	Cardiff Oncology Reports First Quarter 2026 Results and Provides Business Update (GlobeNewswire)
Apr-28-26 04:01PM	Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Apr-27-26 07:00AM	Cardiff Oncology to Host Key Opinion Leader Discussion on Onvansertib's Promising Single-Agent Activity (GlobeNewswire)
Apr-21-26 10:00AM	Cardiff Oncology to Present Updated Phase 2 Data of Onvansertib in First-Line RAS-Mutated mCRC in a Rapid Oral Session at ASCO 2026 (GlobeNewswire) -7.30%
Apr-17-26 04:01PM	Cardiff Oncology Presents Preclinical Data on its PLK1 Inhibitor Onvansertib in Combination with a HER2-Targeted ADC at the 2026 AACR Annual Meeting (GlobeNewswire) +6.51%
Apr-09-26 04:01PM	Cardiff Oncology Announces Key Leadership Appointments to Strengthen Executive Team for Next Phase of Growth (GlobeNewswire) +7.05% -5.39%
Mar-27-26 08:05AM	These 16 stocks are a short seller's dream - likely losers no matter what the market does (MarketWatch) -7.19%
Mar-20-26 07:00AM	Cardiff Oncology to Host Key Opinion Leader Discussion Focusing on First-Line RAS-mutated Metastatic Colorectal Cancer (GlobeNewswire)
Mar-19-26 07:00AM	Cardiff Oncology to Present Preclinical Data with Highly Specific PLK1 Inhibitor Onvansertib at the 2026 AACR Annual Meeting (GlobeNewswire)
04:01PM	Loading…
Feb-26-26 04:01PM	Cardiff Oncology to Participate in Three Upcoming Investor Conferences (GlobeNewswire)
04:32AM	Cardiff Oncology Spotlights Onvansertib Data at Oppenheimer: 72% ORR in RAS-Mutant mCRC (MarketBeat)
Feb-24-26 05:26PM	Cardiff Oncology: Q4 Earnings Snapshot (Associated Press Finance) +8.97% +12.35%
04:30PM	Cardiff Oncology Reports Full Year 2025 Results and Provides Business Update (GlobeNewswire)
Feb-19-26 07:00AM	Cardiff Oncology to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference (GlobeNewswire)
Jan-28-26 06:23AM	Cardiff Oncology Stock Plunges After Sudden Leadership Change, Narrowed Trial Focus (Benzinga) -19.00%
Jan-27-26 10:54AM	Cardiff Oncology Taps Interim CEO, Picks 30mg Onvansertib Regimen for 2026 Registrational mCRC Study (MarketBeat) -31.97%
07:05AM	Cardiff Oncology Announces Positive Update from its Randomized Phase 2 Trial of Onvansertib in First-line RAS-mutated mCRC (GlobeNewswire)
07:00AM	Cardiff Oncology Announces Executive Leadership Changes as it Transitions to Late-Stage Clinical Development (GlobeNewswire)
Dec-08-25 04:05PM	Cardiff Oncology Announces Clinical Data from Investigator-Sponsored Trial with Onvansertib in Chronic Myelomonocytic Leukemia at ASH 2025 (GlobeNewswire) +10.90%
07:00AM	Cardiff Oncology to Present at Sidoti's Year-End Virtual Investor Conference (GlobeNewswire)
Nov-24-25 07:00AM	Cardiff Oncology to Present at the Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire)
Nov-06-25 04:33PM	Cardiff Oncology: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Cardiff Oncology Reports Third Quarter 2025 Results and Provides Business Update (GlobeNewswire)
Nov-04-25 04:01PM	Cardiff Oncology to Participate in Two Upcoming Investor Conferences (GlobeNewswire)
04:05PM	Loading…
Oct-02-25 04:05PM	Cardiff Oncology to Participate in Two Upcoming Investor Conferences (GlobeNewswire)
Aug-28-25 04:05PM	Cardiff Oncology to Participate in Three Upcoming Investor Conferences (GlobeNewswire)
Jul-29-25 05:25PM	Cardiff Oncology (CRDF) Reports Q2 Loss, Lags Revenue Estimates (Zacks) -11.26% -24.77%
04:23PM	Cardiff Oncology: Q2 Earnings Snapshot (Associated Press Finance)
04:07PM	Cardiff Oncology Announces Positive Data from Ongoing Randomized Phase 2 First-line RAS-mutated mCRC Clinical Trial (CRDF-004) (GlobeNewswire)
04:05PM	Cardiff Oncology Reports Second Quarter 2025 Results and Provides Business Update (GlobeNewswire)
Jun-19-25 09:25AM	Cardiff Oncology to share CRDF-004 trial data on July 29 (TipRanks)
09:25AM	Cardiff selloff brings attractive entry point, says H.C. Wainwright (TipRanks)
Jun-17-25 04:05PM	Cardiff Oncology Appoints Dr. Roger Sidhu as Chief Medical Officer and Announces Timing for the Next Update from the CRDF-004 Trial in First-Line RAS-mutated mCRC (GlobeNewswire) -18.38%
Jun-02-25 04:05PM	Cardiff Oncology Announces Positive Data from Investigator-Initiated Trial of Onvansertib in Combination with Paclitaxel in Metastatic Triple-Negative Breast Cancer Presented at ASCO 2025 (GlobeNewswire)
May-14-25 12:00PM	Cardiff Oncology (CRDF) Upgraded to Buy: Here's What You Should Know (Zacks)
May-08-25 05:25PM	Cardiff Oncology (CRDF) Reports Q1 Loss, Lags Revenue Estimates (Zacks) +5.62%
04:05PM	Cardiff Oncology Reports First Quarter 2025 Results and Provides Business Update (GlobeNewswire)
May-02-25 03:35AM	Cardiff Oncology: Expecting Massive Updates In Colon Cancer Soon (Seeking Alpha)
Apr-28-25 10:00AM	ADC Therapeutics SA (ADCT) May Report Negative Earnings: Know the Trend Ahead of Q1 Release (Zacks)
Apr-24-25 10:01AM	Cardiff Oncology (CRDF) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Apr-23-25 04:05PM	Cardiff Oncology Announces a Second Patent for the Treatment of mCRC for Bev-Naive Patients (GlobeNewswire)
04:05PM	Cardiff Oncology Announces a Second Patent for the Treatment of mCRC for Bev-Na ve Patients (GlobeNewswire)
Apr-15-25 04:10PM	Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +5.38%
04:05PM	Cardiff Oncology Announces Completion of Enrollment in Phase 2 CRDF-004 Trial Evaluating Onvansertib for the Treatment of First-line RAS-mutated Metastatic Colorectal Cancer (GlobeNewswire)
Mar-26-25 03:57PM	Is Cardiff Oncology, Inc. (CRDF) The Hot Biotech Stock Under $5? (InsiderMonkey) -6.84%
Mar-08-25 07:33AM	Why the Global Cancer Market Could Surpass $900 Billion--And the Stocks Leading the Charge (PR Newswire)
Feb-27-25 04:05PM	Cardiff Oncology Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update (GlobeNewswire) -8.97%
Feb-26-25 08:12AM	Cardiff Oncology Inc (CRDF) Q4 2024 Earnings Report Preview: What To Look For (GuruFocus.com) +5.44%
Feb-24-25 04:05PM	Cardiff Oncology to Present at Upcoming Investor Conferences (GlobeNewswire) -7.24%
Feb-20-25 04:05PM	Cardiff Oncology to Report Fourth Quarter 2024 Results and Provide Business Update (GlobeNewswire)
Dec-26-24 09:00AM	Achievements and Progress Heading into 2025 for Oncology Treatments and Therapies Fuel an Optimistic Outlook (GlobeNewswire) +10.71%
Dec-20-24 12:52PM	Oncology Advancements Accelerate Amid Rising Early-Onset Cancer Diagnoses (PR Newswire) -5.12%
Dec-18-24 11:12AM	Cancer Care Disruptions Highlight Growing Demand for Innovative Oncology Treatments (PR Newswire) -16.07%
Dec-14-24 06:50AM	Cardiff Oncology price target raised to $10 from $7 at Piper Sandler (TipRanks)
Dec-11-24 07:19AM	Cardiff Oncology Reports Promising Phase 2 Trial Results (TipRanks)
Dec-10-24 07:20AM	Cardiff Oncology Prices Oversubscribed $40 Million Underwritten Registered Direct Offering (GlobeNewswire) +54.92%
06:00AM	Cardiff Oncology Announces Positive Initial Data from First-line RAS-mutated mCRC Clinical Trial (GlobeNewswire)
Nov-19-24 08:00AM	Cardiff Oncology Announces New Patent with Claims for the Use of Onvansertib in Treating KRAS mutated mCRC (GlobeNewswire)
Nov-07-24 04:05PM	Cardiff Oncology Reports Third Quarter 2024 Results and Provides Business Update (GlobeNewswire) +7.35% -24.69%
Oct-30-24 04:30PM	Cardiff Oncology Announces Journal of Clinical Oncology Publication of Data from Phase 2 Trial in Second-line KRAS Mutant mCRC (GlobeNewswire)
Aug-08-24 04:05PM	Cardiff Oncology Reports Second Quarter 2024 Results and Provides Business Update (GlobeNewswire) +11.74%
Aug-01-24 04:05PM	Cardiff Oncology to Report Second Quarter 2024 Results and Provide Business Update (GlobeNewswire)
May-29-24 04:05PM	Cardiff Oncology to Present at the Jefferies Healthcare Conference (GlobeNewswire)
May-13-24 04:05PM	Cardiff Oncology to Present at Upcoming Investor Conferences in May (GlobeNewswire)
May-09-24 12:15PM	Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036 (PR Newswire) +5.63%
May-07-24 06:00AM	The $5 Phenoms: 3 Cheap Stocks That Could Skyrocket by 2028 (InvestorPlace)
May-02-24 09:54PM	CRDF Stock Earnings: Cardiff Oncology Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace) +5.91% -21.43%
05:45PM	Cardiff Oncology (CRDF) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Cardiff Oncology Reports First Quarter 2024 Results and Provides Business Update (GlobeNewswire)
Apr-25-24 04:05PM	Cardiff Oncology to Report First Quarter 2024 Results and Provide Business Update (GlobeNewswire)
Apr-08-24 04:05PM	Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS-mutated mCRC Clinical Study (GlobeNewswire)
Apr-01-24 08:50AM	Cardiff Oncology (CRDF) Is a Great Choice for 'Trend' Investors, Here's Why (Zacks) +7.30%
Mar-21-24 07:55AM	Cardiff (CRDF) Stock Rallies 194% in a Month: Here's Why (Zacks)
Mar-14-24 08:50AM	Here's Why Momentum in Cardiff Oncology (CRDF) Should Keep going (Zacks)
08:08AM	Cardiff Oncology (CRDF) Moves 20.5% Higher: Will This Strength Last? (Zacks)
Mar-06-24 04:05PM	Cardiff Oncology Announces Upcoming Presentations at the AACR Annual Meeting 2024 (GlobeNewswire) +6.58% -9.77%
12:00PM	What Makes Cardiff Oncology (CRDF) a Strong Momentum Stock: Buy Now? (Zacks)
Mar-01-24 10:12AM	Cardiff Oncology Inc (CRDF) Reports Q4 and Full Year 2023 Financial Results (GuruFocus.com) +64.87%
Feb-29-24 07:40PM	Cardiff Oncology (CRDF) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:07PM	Cardiff Oncology Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update (GlobeNewswire)
04:06PM	Cardiff Oncology Provides Clinical Update on Phase 2 Randomized Second-line ONSEMBLE Trial in Patients with RAS-mutated mCRC (GlobeNewswire)
04:05PM	Cardiff Oncology Announces First Patient Dosed in Randomized First-line RAS-mutated Metastatic Colorectal Cancer Trial (CRDF-004) (GlobeNewswire)
Feb-26-24 08:00AM	Cardiff Oncology to Present at the Cowen 44th Annual Health Care Conference (GlobeNewswire)
Feb-22-24 08:00AM	Cardiff Oncology to Report Fourth Quarter and Full Year 2023 Results and Provide Business Update (GlobeNewswire)
Jan-17-24 10:30AM	Cardiff Oncology Announces Publication of Data from Phase 1b study in second-line KRAS-mutated mCRC in Clinical Cancer Research (PR Newswire) -9.82%
Nov-20-23 04:05PM	Cardiff Oncology to Present at the 35th Annual Piper Sandler Healthcare Conference (PR Newswire)
Nov-02-23 04:05PM	Cardiff Oncology Reports Third Quarter 2023 Results and Provides Business Update (PR Newswire) +8.57%
Oct-26-23 04:05PM	Cardiff Oncology to Report Third Quarter 2023 Financial Results and Provide Business Update (PR Newswire)
Oct-23-23 08:45AM	Rising Number of Studies to Develop Novel Therapies For Pancreatic Ductal Adenocarcinoma (PDAC) Intensely Increasing (PR Newswire) -10.27%
Oct-11-23 09:35AM	Cardiff Oncology (CRDF) Loses -29.75% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Sep-26-23 04:05PM	Cardiff Oncology Announces Positive Clinical Data in Pancreatic Cancer and Small Cell Lung Cancer, including Single-Agent Activity from Onvansertib Monotherapy (PR Newswire)
Sep-05-23 08:00AM	Cardiff Oncology to Present at Upcoming Investor Conferences in September (PR Newswire)
Aug-09-23 04:05PM	Cardiff Oncology Reports Second Quarter 2023 Results and Provides Business Update (PR Newswire) -12.39% +8.38%
Aug-07-23 04:05PM	Cardiff Oncology Announces New Lead Program in First-Line Metastatic Colorectal Cancer and Expanded Pfizer Relationship (PR Newswire) -8.19% +38.85%

Cardiff Oncology, Inc. is an oncology therapeutics company, which engages in the development of drugs that target mitosis for the treatment of various types of cancer. The firm is focused on developing onvansertib, a first-in-class, third-generation Polo-like Kinase 1 (PLK1) inhibitor, in combination with standard-of-care chemotherapy and targeted therapeutics. Its clinical programs include KRAS-Mutated Metastatic Colorectal Cancer (mCRC), Resistant Metastatic Castration-Resistant Prostate Cancer (mCRPC) and relapsed or refractory Acute Myeloid Leukemia (AML). The company was founded by Gabriel M. Cerrone, L. David Tomei, Samuil Umansky, and Hovsep Melkonyan in 1999 and is headquartered in San Diego, CA.

PresidentDr. Mani Mohindru Ph.D.

M.D.Dr. Roger Sidhu FRCPC

M.B.A.Mr. Josh Muntner BFA

M.D.Dr. Ajay Aggarwal M.B.A.

Chief Accounting OfficerMs. Brigitte Lindsay

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
PACE GARY W	Director	Jul 14 '26	Buy	1.46	687,285	1,000,000	2,043,661	Jul 16 04:03 PM
Mohindru Mani	Chief Executive Officer	Jul 14 '26	Buy	1.46	34,364	50,000	59,067	Jul 16 04:01 PM
Mohindru Mani	Chief Executive Officer	Jun 18 '26	Buy	1.21	24,703	29,891	24,703	Jun 22 09:00 AM
PACE GARY W	Director	Jun 18 '26	Buy	1.22	30,000	36,600	1,356,376	Jun 22 09:00 AM
PACE GARY W	Director	Jul 30 '25	Buy	2.45	275,000	673,750	1,330,676	Jul 31 04:05 PM
PACE GARY W	Director	Jul 30 '25	Buy	2.45	15,000	36,750	1,345,676	Jul 31 04:05 PM

Open in Screener

VIRC

Virco Manufacturing Corp

6.06

Jul 16 • 03:59PM ET +0.01 (0.17%)

6.06

Aftermarket • 05:00PM ET 0.00 (0.00%)

Consumer Cyclical Furnishings, Fixtures & Appliances USA Micro NASD

VIRC Virco Manufacturing Corp daily Stock Chart

Peers: HOFT FLXS HBB LCUT BSET COOK KEQU LOVE ETD LZB

| Held by: VTI AVUV VXF DFAT DFSV DFMC DES BSVO IWC DFAS

Index	-
Market Cap	95.32M
Enterprise Value	130.35M
Income	-0.94M
Sales	196.59M
Book/sh	6.51
Cash/sh	0.24
Dividend Est.	-
Dividend TTM	0.10 (1.65%)
Dividend Ex-Date	Jun 18, 2026
Dividend Gr. 3/5Y	- -
Payout	61.43%
Employees	731
IPO	Mar 08, 1977

P/E	-
Forward P/E	18.36
PEG	0.37
P/S	0.48
P/B	0.93
P/C	25.55
P/FCF	20.15
EV/EBITDA	21.13
EV/Sales	0.66
Quick Ratio	0.90
Current Ratio	2.71
Debt/Eq	0.38
LT Debt/Eq	0.31
Option/Short	Yes / Yes

EPS (ttm)	-0.06
EPS next Y	0.33
EPS next Q	0.07
EPS this Y	-93.75%
EPS next Y	3200.00%
EPS next 5Y	49.07%
EPS past 3/5Y	-45.79% -
Sales past 3/5Y	-4.75% 5.50%
EPS Y/Y TTM	-104.75%
Sales Y/Y TTM	-22.38%
EPS Q/Q	-480.39%
Sales Q/Q	-9.07%
Earnings	Jun 03 BMO
EPS/Sales Surpr.	-1900.00% 12.84%

Insider Own	16.22%
Insider Trans	1.81%
Inst Own	48.19%
Inst Trans	-3.22%
ROA	-0.52%
ROE	-0.90%
ROIC	-0.70%
Gross Margin	39.43%
Oper. Margin	0.05%
Profit Margin	-0.48%
SMA20	-2.70%
SMA50	-0.83%
SMA200	-6.13%
Trades

Shs Outstand	15.73M
Shs Float	13.18M
Short Float	2.31%
Short Ratio	4.34
Short Interest	0.30M
52W High	9.09 -33.30%
52W Low	5.16 17.56%
Volatility	2.81% 4.31%
ATR (14)	0.24
RSI (14)	46.85
Beta	0.21
Rel Volume	0.31
Avg Volume	70.24K
Volume	21,467

Perf Week	-0.66%
Perf Month	-3.81%
Perf Quarter	-0.49%
Perf Half Y	-4.11%
Perf YTD	-5.16%
Perf Year	-23.68%
Perf 3Y	51.12%
Perf 5Y	76.68%
Perf 10Y	24.95%
Recom	3.00
Target Price	6.50
Prev Close	6.05
Price	6.06
Change	0.17%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-21-17	Resumed	Wedbush	Outperform	$5 → $6
Apr-20-09	Reiterated	Wedbush Morgan	Hold	$2.75 → $3
Dec-15-08	Reiterated	Wedbush Morgan	Hold	$5 → $2.75
Sep-12-08	Reiterated	Wedbush Morgan	Hold	$5.75 → $5
Dec-11-07	Reiterated	Wedbush Morgan	Hold	$8 → $7.50
Sep-12-07	Reiterated	Wedbush Morgan	Hold	$7.50 → $8

Jun-03-26 08:30AM	Virco Reports $2.8 Million First Quarter Loss as Demand for School Furniture Slows (GlobeNewswire) -9.48%
Apr-08-26 08:30AM	Virco Reports Full Year Net Income of $2.6 Million on Revenue of $199.7 Million (GlobeNewswire) -5.33%
Dec-08-25 08:30AM	Virco Reports Loss of $1.3 Million in Third Quarter as Cyclical Decline Begins to Slow (GlobeNewswire) -6.05%
Sep-05-25 09:45AM	Virco Manufacturing Corporation (VIRC) Q2 Earnings and Revenues Miss Estimates (Zacks)
08:30AM	Virco Reports Solid Operating and Net Income for Second Quarter and First Six Months, Despite Significant Reduction in Revenue (GlobeNewswire)
05:20PM	Loading…
Aug-18-25 05:20PM	Flexsteel Industries (FLXS) Beats Q4 Earnings and Revenue Estimates (Zacks)
Aug-11-25 07:00PM	iHeartMedia (IHRT) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
Jul-25-25 09:40AM	Should Value Investors Buy Virco Manufacturing (VIRC) Stock? (Zacks)
Jul-09-25 09:40AM	Should Value Investors Buy Virco Manufacturing (VIRC) Stock? (Zacks)
Jun-27-25 04:27AM	Zacks Industry Outlook Highlights Sleep Number and Virco (Zacks)
Jun-26-25 10:59AM	2 Furniture Stocks to Buy From Promising Industry Landscape (Zacks)
Jun-23-25 09:40AM	Are Investors Undervaluing Virco Manufacturing (VIRC) Right Now? (Zacks) +8.19%
09:04AM	Best Value Stocks to Buy for June 23rd (Zacks)
04:52AM	Best Income Stocks to Buy for June 23rd (Zacks)
Jun-06-25 09:45AM	Virco Manufacturing Corporation (VIRC) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
08:30AM	Loading…
08:30AM	Virco Reports $700,000 First Quarter Profit as Demand for School Furniture Slows (GlobeNewswire)
May-01-25 05:42PM	Virco: Despite Possible Positives, Still Not Cheap Enough To Warrant A Buy (Seeking Alpha)
Apr-15-25 12:28PM	Virco Q4 Loss Wider-Than-Expected, Sales Miss Estimates, Stock Down (Zacks)
Apr-14-25 08:30AM	Virco Marks 75th Anniversary with Strong Earnings Results, Positive Cash Flow, Higher Shareholder Returns, and Strategic Re-Investment (GlobeNewswire)
Mar-26-25 05:30PM	MillerKnoll (MLKN) Matches Q3 Earnings Estimates (Zacks)
Jan-21-25 08:30AM	Virco Adopts New Share Repurchase Program (GlobeNewswire) +12.94%
Dec-09-24 09:45AM	Virco Manufacturing Corporation (VIRC) Lags Q3 Earnings and Revenue Estimates (Zacks) -17.72%
08:30AM	Virco Reports Third Quarter Results: Robust Balance Sheet and Strengthening Cash Flows as School Furniture Market Returns to pre-Pandemic Seasonal Patterns (GlobeNewswire)
Oct-30-24 04:37PM	Is Virco Mfg. Corporation (VIRC) The Best Furniture Stock To Invest In According To Analysts? (Insider Monkey)
Sep-09-24 09:50AM	Virco Manufacturing Corporation (VIRC) Surpasses Q2 Earnings Estimates (Zacks) -9.25%
08:30AM	Virco Reports Improved Financial Position Following Record Second Quarter and First Half Results (GlobeNewswire)
Aug-01-24 09:40AM	Is Virco Manufacturing (VIRC) Stock Undervalued Right Now? (Zacks)
08:50AM	Here's Why Momentum in Virco Manufacturing (VIRC) Should Keep going (Zacks)
Jul-17-24 06:31PM	Is Virco Mfg. Corporation (VIRC) the Best Small-Cap Stock to Buy Right Now? (Insider Monkey)
Jul-16-24 09:40AM	Should Value Investors Buy Virco Manufacturing (VIRC) Stock? (Zacks)
08:50AM	Loading…
08:50AM	Virco Manufacturing (VIRC) is on the Move, Here's Why the Trend Could be Sustainable (Zacks)
Jul-02-24 07:37PM	Virco Manufacturing (VIRC) and BRF (BRFS) Are Aggressive Growth Stocks (Zacks)
Jun-12-24 09:40AM	Are Investors Undervaluing Virco Manufacturing (VIRC) Right Now? (Zacks)
08:50AM	Recent Price Trend in Virco Manufacturing (VIRC) is Your Friend, Here's Why (Zacks)
Jun-10-24 08:42AM	Virco's (VIRC) Shares Gain on Q1 Earnings & Net Sales Beat (Zacks) +18.88%
Jun-07-24 12:52PM	VIRC Stock Earnings: Virco Mfg Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace) +21.45%
09:50AM	Virco Manufacturing Corporation (VIRC) Beats Q1 Earnings and Revenue Estimates (Zacks)
08:30AM	Virco Reports 33.7% Increase in First Quarter Revenue; Net Income of $2.1 million; Declares Regular Quarterly Dividend (GlobeNewswire)
May-30-24 03:23PM	Sixfold Fortunes: 3 Bargain Stocks Set for 6X Gains by 2030 (InvestorPlace)
Apr-15-24 10:48AM	Virco (VIRC) Reports Loss for Q4 Despite Higher Net Revenues (Zacks) -14.71%
Apr-12-24 10:10AM	Virco Manufacturing Corporation (VIRC) Reports Q4 Loss, Tops Revenue Estimates (Zacks) +6.54%
09:00AM	Virco Reports Full Year Revenue Increased 16.5% to $269.1 million, delivering 32.4% growth in Net Income (GlobeNewswire)
Apr-01-24 08:30AM	Virco Issues Updated Investor Presentation (GlobeNewswire)
Feb-27-24 08:00AM	Virco Announces First Quarter Cash Dividend (GlobeNewswire) +5.42%
Jan-24-24 09:15AM	Virco Manufacturing Corporation (VIRC) Hits Fresh High: Is There Still Room to Run? (Zacks)
Jan-23-24 08:50AM	Virco Manufacturing Corporation (VIRC) Is a Great Choice for 'Trend' Investors, Here's Why (Zacks)
Jan-18-24 09:40AM	Should Value Investors Buy Virco Manufacturing (VIRC) Stock? (Zacks)
Jan-05-24 09:15AM	Virco Manufacturing Corporation (VIRC) Hit a 52 Week High, Can the Run Continue? (Zacks)
Jan-02-24 08:50AM	Here's Why Momentum in Virco Manufacturing Corporation (VIRC) Should Keep going (Zacks) -6.57%
Dec-28-23 12:00PM	Are You Looking for a Top Momentum Pick? Why Virco Manufacturing Corporation (VIRC) is a Great Choice (Zacks)
Dec-21-23 09:40AM	Are Investors Undervaluing Virco Manufacturing (VIRC) Right Now? (Zacks)
Dec-18-23 09:25AM	Virco Manufacturing Corporation (VIRC) Soars to 52-Week High, Time to Cash Out? (Zacks)
Dec-14-23 08:50AM	Here's What Could Help Virco Manufacturing Corporation (VIRC) Maintain Its Recent Price Strength (Zacks)
Dec-09-23 07:28PM	Virco Manufacturing Corp Reports Record Q3 and YTD Financials; Initiates Dividend and Share Buyback (GuruFocus.com)
Dec-08-23 08:10AM	Virco Manufacturing Corporation (VIRC) Surpasses Q3 Earnings and Revenue Estimates (Zacks) +21.40%
07:00AM	Virco Reports Record 3rd Quarter and YTD Results (GlobeNewswire)
Oct-17-23 08:50AM	What Makes Virco Manufacturing Corporation (VIRC) a Good Fit for 'Trend Investing' (Zacks)
Sep-29-23 08:50AM	Virco Manufacturing Corporation (VIRC) is on the Move, Here's Why the Trend Could be Sustainable (Zacks) +9.52%
Sep-13-23 10:00AM	Best Momentum Stock to Buy for September 13th (Zacks)
08:50AM	Virco Manufacturing Corporation (VIRC) is on the Move, Here's Why the Trend Could be Sustainable (Zacks)
08:47AM	Best Value Stocks to Buy for September 13th (Zacks)
Sep-11-23 10:15AM	Virco Manufacturing Corporation (VIRC) Surpasses Q2 Earnings and Revenue Estimates (Zacks) +9.48%
08:30AM	Virco Operating Income Nearly Doubles as Second Quarter Revenue Jumps 30% (GlobeNewswire)
Sep-07-23 09:40AM	Toro (TTC) Q3 Earnings and Revenues Lag Estimates (Zacks)
Aug-22-23 08:50AM	Sphere Entertainment (SPHR) Beats Q4 Earnings Estimates (Zacks)
Jul-31-23 06:05AM	Investors in Virco Mfg (NASDAQ:VIRC) have seen decent returns of 100% over the past three years (Simply Wall St.)
Jul-25-23 09:40AM	Should Value Investors Buy Virco Manufacturing (VIRC) Stock? (Zacks)
Jul-24-23 08:10AM	Best Value Stocks to Buy for July 24th (Zacks)
07:12AM	Daily Vickers Top Buyers & Sellers for 07/24/2023 (Argus Research)
Jul-17-23 09:40AM	Is American Woodmark (AMWD) Stock Undervalued Right Now? (Zacks)
Jul-14-23 06:38AM	Virco Mfg. Corporation's (NASDAQ:VIRC) Share Price Is Matching Sentiment Around Its Revenues (Simply Wall St.)
Jun-30-23 09:40AM	Are Investors Undervaluing Virco Manufacturing (VIRC) Right Now? (Zacks)
Jun-14-23 09:40AM	Should Value Investors Buy Virco Manufacturing (VIRC) Stock? (Zacks)
Jun-12-23 08:45AM	Virco Manufacturing Corporation (VIRC) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +8.63%
07:30AM	Virco Reports 8.7% Increase in First Quarter Revenue and 16.4% Increase in Shipments + Backlog (GlobeNewswire)
May-21-23 10:46AM	Should You Investigate Virco Mfg. Corporation (NASDAQ:VIRC) At US$3.97? (Simply Wall St.)
Apr-30-23 08:05AM	Virco Mfg. Corporation's (NASDAQ:VIRC) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? (Simply Wall St.)
Apr-28-23 10:45AM	Virco Manufacturing Corporation (VIRC) Q4 Earnings Top Estimates (Zacks)
09:30AM	Virco Reports Full Year Revenue Increased 25% to $231.1 Million, Delivering Operating Income of $10.8 Million (GlobeNewswire)
Mar-26-23 08:16AM	Virco Mfg (NASDAQ:VIRC) Is Doing The Right Things To Multiply Its Share Price (Simply Wall St.)
Feb-13-23 12:15PM	Those who invested in Virco Mfg (NASDAQ:VIRC) a year ago are up 58% (Simply Wall St.)
Jan-26-23 09:40AM	Are Investors Undervaluing Virco Manufacturing (VIRC) Right Now? (Zacks)
Jan-16-23 09:40AM	Is Virco Manufacturing (VIRC) Stock Outpacing Its Consumer Discretionary Peers This Year? (Zacks)
09:40AM	Are Investors Undervaluing Flexsteel Industries (FLXS) Right Now? (Zacks)
Jan-13-23 05:00AM	Zacks.com featured highlights Expro Group Holdings, Banco Bilbao Viscaya Argentaria and Virco Manufacturing (Zacks)
Jan-12-23 07:51AM	3 Top Breakout Stocks Worth a Buy in 2023 (Zacks)
Dec-28-22 09:40AM	Is Virco Manufacturing (VIRC) Stock Undervalued Right Now? (Zacks)
Dec-27-22 07:42AM	Best Value Stocks to Buy for December 27th (Zacks)
Dec-19-22 09:40AM	Is Flexsteel Industries (FLXS) Stock Undervalued Right Now? (Zacks) +5.25%
Dec-16-22 09:40AM	Is TAL Education Group (TAL) Stock Outpacing Its Consumer Discretionary Peers This Year? (Zacks) -6.10%
08:59AM	Virco Mfg Third Quarter 2023 Earnings: EPS Beats Expectations, Revenues Lag (Simply Wall St.)
Dec-14-22 12:00PM	What Makes Virco Manufacturing Corporation (VIRC) a New Buy Stock (Zacks)
Dec-12-22 08:45AM	Virco Manufacturing Corporation (VIRC) Q3 Earnings Beat Estimates (Zacks) +8.40%
07:30AM	Virco Reports Third Quarter Revenue Increased 35%, Driving Improved Financial Performance Across Multiple Metrics (GlobeNewswire)
Nov-18-22 07:45AM	New Strong Buy Stocks for November 18th (Zacks)
Nov-08-22 09:40AM	Is TAL Education Group (TAL) Outperforming Other Consumer Discretionary Stocks This Year? (Zacks)
Oct-17-22 06:46AM	These Return Metrics Don't Make Virco Mfg (NASDAQ:VIRC) Look Too Strong (Simply Wall St.)
Oct-13-22 09:40AM	Is New Oriental Education & Technology Group (EDU) Stock Outpacing Its Consumer Discretionary Peers This Year? (Zacks)
Sep-27-22 09:40AM	Is Trip.com Group Limited (TCOM) Outperforming Other Consumer Discretionary Stocks This Year? (Zacks)
07:34AM	Zacks Industry Outlook Highlights WillScot Mobile Mini, La-Z-Boy and Virco (Zacks)

Virco Manufacturing Corp. engages in the design, production and distribution of furniture. Its products include mobile tables, mobile storage equipment, desks, computer furniture, chairs, foldable chairs and foldable tables. The company was founded in February 1950 and is headquartered in Torrance, CA.

Chairman of the Board & CEOMr. Robert A. Virtue

President & DirectorMr. Douglas A. Virtue

Senior VP of FinanceMs. Bassey Yau

VP of Sales & DirectorMs. Kathy Virtue Young

Senior VP & COOMr. J. Scott Bell

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
VIRTUE DOUGLAS A	Executive Vice President	Jul 15 '26	Buy	6.00	5,140	30,838	893,808	Jul 16 04:32 PM
VIRTUE DOUGLAS A	Executive Vice President	Jul 16 '26	Buy	6.00	600	3,600	894,408	Jul 16 04:32 PM
VIRTUE DOUGLAS A	Executive Vice President	Jul 08 '26	Buy	6.00	8,083	48,474	888,663	Jul 09 04:36 PM
VIRTUE DOUGLAS A	Executive Vice President	Jul 09 '26	Buy	6.00	5	30	888,668	Jul 09 04:36 PM
VIRTUE DOUGLAS A	Executive Vice President	Jun 29 '26	Buy	6.00	1,400	8,400	880,580	Jun 30 04:50 PM
VIRTUE ROBERT A	CEO	Jun 11 '26	Buy	6.22	4,300	26,758	506,124	Jun 15 01:29 PM
VIRTUE DOUGLAS A	Executive Vice President	Jun 09 '26	Buy	6.00	1,314	7,884	879,180	Jun 11 03:23 PM
VIRTUE DOUGLAS A	Executive Vice President	Apr 15 '26	Buy	6.09	11,678	71,119	877,866	Apr 15 05:34 PM
VIRTUE DOUGLAS A	Executive Vice President	Apr 14 '26	Buy	6.07	4,349	26,398	866,188	Apr 15 05:34 PM
Lind Robert R	Director	Apr 15 '26	Buy	6.07	500	3,035	119,890	Apr 15 03:03 PM
VIRTUE ROBERT A	CEO	Apr 14 '26	Buy	6.22	2,700	16,794	501,824	Apr 14 02:57 PM
RICHARDSON BRADLEY C	Director	Apr 10 '26	Buy	5.59	1,600	8,944	39,354	Apr 13 04:29 PM
RICHARDSON BRADLEY C	Director	Apr 13 '26	Buy	5.63	400	2,252	39,754	Apr 13 04:29 PM
VIRTUE ROBERT A	CEO	Apr 10 '26	Buy	5.52	3,300	18,216	499,124	Apr 13 04:28 PM
VIRTUE ROBERT A	CEO	Jan 13 '26	Buy	6.32	2,500	15,800	495,824	Jan 13 05:29 PM
RICHARDSON BRADLEY C	Director	Jan 07 '26	Buy	6.50	2,000	13,009	37,754	Jan 07 04:19 PM
VIRTUE DOUGLAS A	Executive Vice President	Oct 17 '25	Buy	7.34	13,022	95,581	861,839	Oct 17 05:09 PM
VIRTUE ROBERT A	CEO	Oct 16 '25	Buy	6.96	5,000	34,800	493,324	Oct 16 04:49 PM

CRDF

Cardiff Oncology Inc

VIRC

Virco Manufacturing Corp

Upgrade your Finviz experience